2-Chloro-8-fluoro-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one

Catalog No.: 
ACAQBZ101
CAS No.: 
1956331-70-6
Molecular Formula: 
C13H10ClFN4O
Molecular Weight: 
292.70
2-Chloro-8-fluoro-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%
1g97%
5g97%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-8-fluoro-5,11-dimethyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one
IUPAC Name2-chloro-8-fluoro-5,11-dimethyl-5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one
Molecular FormulaC13H10ClFN4O
Molecular Weight292.70
SMILESO=C1C2=CC(F)=CC=C2N(C)C3=NC(Cl)=NC=C3N1C
InChI KeyNKIQWCBUQWWJJS-UHFFFAOYSA-N
Synonym6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 2-chloro-8-fluoro-5,11-dihydro-5,11-dimethyl-
CAS No.1956331-70-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACAQBZ101 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAQBZ101 route product structure diagram
    ACAQBZ1011956331-70-6
Inquiry

2. ACAQBZ101 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAQBZ101 route product structure diagram
    ACAQBZ1011956331-70-6
Inquiry

3. ACAQBZ101 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAQBZ101 route product structure diagram
    ACAQBZ1011956331-70-6
Inquiry

Comments (0)